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Background
Alzheimer’s disease is one of the most frequent forms of
dementia in the elderly population affecting about 25 %
of people in the age of 80 to 90 years [1]. Due to the
more and more ageing society the importance of demen-
tia is increasing. The brain of affected patients is charac-
terized by the deposition of senile plaques containing
the neurotoxic peptide Ab40-42 that is derived out of its
precursor, the Amyloid Precursor Protein (APP) [2].
Beside its role in Alzheimer’s pathology many physiologi-
cal functions, like stimulation of synaptogenesis and sig-
nal transduction in a receptor-like manner are discussed
for APP [3]. However, until now it was not possible to
correlate the known structures of subdomains with most
of the proposed physiological functions of APP.
Materials and methods
Using X-ray crystallography we solved the structure of
the APP-E1-domain [4] and together with biochemical
methods like isothermal titration calorimetry (ITC), ana-
lytical gelfiltration, limited proteolysis, static and
dynamic light scattering we analysed the dimerization of
APP-E1 and two mutated versions of it.
Results
Here we present the structural and biochemical character-
ization of the APP-E1-domain showing that the growth-
factor-like domain (GFLD) and the copper-binding
domain (CuBD) form one closed structural and hence
functional entity. We could show concentration dependent
self-dimerization of the E1 domain at high and the heparin
dependent dimerization at low protein concentrations and
set up a model of dimerization, which was also based on
crystallographic data. We additionally could prove this
model using our E1 mutants.
Conclusions
We could nicely show the dimerization of the APP-E1
domain and identified the previously described loop
region of the growth factor like domain [5] to be essen-
tial for this dimerization. Together with our structural
data we could for the first time link structure and func-
tion of APP.
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